Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake.

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding vaccine safety. As a result, a growing share of the public is wary of ...

Unlock comprehensive insights into our analysis of Moderna stock here. NasdaqGS:MRNA Earnings Per Share Growth as at Mar 2025 Over the past five years, Moderna's total return, including share ...

Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

NPR reports on the National Institutes of Health funding cuts with insight from two NIH staffers and one person familiar with NIH's activities who requested anonymity because they were not authorized ...

Legislation aimed to ban or limit mRNA vaccines — like Pfizer-BioNTech's covid-19 vaccine — was introduced this year by GOP lawmakers in at least seven states. (Terrence Antonio James/Chicago ...